allbcis.com

Every brain–computer interface on earth

private-startup  ·  clinical-grade  ·  research-grade

Beacon Biosignals

At a glance

Legal name
Beacon Biosignals, Inc.
Aliases
Type
private-startup
Focus areas
clinical-grade, research-grade, data-platform, diagnostic
Founded
Defunct
Spinout of
HQ city
Boston
HQ country
US
Employees
Flagship device
dreem-3
Product lines
1
In-house manufacturing
Yes
Open source
No
GitHub org
Website
beacon.bio
Blog
Support

Devices

People

Current leadership

  1. Beacon Biosignals — acquires Dreem (PR)https://beacon.bio/news/beacon-biosignals-acquires-dreem-launches-at-home-sleep-monitoring-services-for-clinical-trials2023-07-11
Updated: 2026-05-04

  • Jacob Donoghue

    CEO

Milestones

  1. Acquires Dreem R&D business from Rythm

  2. FDA 510(k) K223539 for Dreem 3S

Reputation

EEG-analytics + hardware platform pitched at pharma sleep trials. Inherited Dreem's hardware and dataset; rebranded the Dreem 3S as Waveband in 2025.

Sources